Javascript must be enabled to continue!
Thrombin activates two stress-activated protein kinases, c-Jun N-terminal kinase and p38, in HepG2 cells
View through CrossRef
Recently identified c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase are activated by stimuli of various cellular stresses, cytokines, and growth factors. Strong activation of JNK was reported in the regenerating liver, implicating JNK in growth stimulation of hepatocytes. However, it is not known which factors regulate JNK activity in liver cells. In this study, we examined activation of JNK and p38 in HepG2 cells stimulated with heterotrimeric G protein-coupled receptor agonists known as mitogens. Thrombin, lysophosphatidic acid (LPA), and bradykinin (BK) stimulated extracellular signal-regulated protein kinase to similar extents, indicating that HepG2 cells have cell surface receptors for these agonists, which are coupled to intracellular signaling pathways. In contrast, only thrombin strongly activated JNK and p38. Thrombin-induced activation of JNK and p38 peaked at 30 minutes and 15 minutes with maximal stimulation of 13- and 4-fold increases, respectively. LPA and BK failed to activate JNK at all and activated p38 only slightly. Interestingly, thrombin-induced JNK activation was inhibited by protein kinase C down-regulation and the addition of a specific protein kinase C inhibitor. Short-term stimulation of cells with an active phorbol ester also induced JNK activation in HepG2 cells. These results indicate that thrombin is a relatively strong activator for JNK and p38 and might play a role in the regulation of activities of JNK and p38 in liver cells.
Ovid Technologies (Wolters Kluwer Health)
Title: Thrombin activates two stress-activated protein kinases, c-Jun N-terminal kinase and p38, in HepG2 cells
Description:
Recently identified c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase are activated by stimuli of various cellular stresses, cytokines, and growth factors.
Strong activation of JNK was reported in the regenerating liver, implicating JNK in growth stimulation of hepatocytes.
However, it is not known which factors regulate JNK activity in liver cells.
In this study, we examined activation of JNK and p38 in HepG2 cells stimulated with heterotrimeric G protein-coupled receptor agonists known as mitogens.
Thrombin, lysophosphatidic acid (LPA), and bradykinin (BK) stimulated extracellular signal-regulated protein kinase to similar extents, indicating that HepG2 cells have cell surface receptors for these agonists, which are coupled to intracellular signaling pathways.
In contrast, only thrombin strongly activated JNK and p38.
Thrombin-induced activation of JNK and p38 peaked at 30 minutes and 15 minutes with maximal stimulation of 13- and 4-fold increases, respectively.
LPA and BK failed to activate JNK at all and activated p38 only slightly.
Interestingly, thrombin-induced JNK activation was inhibited by protein kinase C down-regulation and the addition of a specific protein kinase C inhibitor.
Short-term stimulation of cells with an active phorbol ester also induced JNK activation in HepG2 cells.
These results indicate that thrombin is a relatively strong activator for JNK and p38 and might play a role in the regulation of activities of JNK and p38 in liver cells.
Related Results
Tracking and Inhibiting Atypical Vascular Inflammation
Tracking and Inhibiting Atypical Vascular Inflammation
Mitogen‐activated protein kinase (MAPK) p38 drives the onset and progression of many clinically challenging diseases. However, three decades of research have failed to yield clinic...
Thrombin Induces Protease Activated Receptor (PAR)-3/-4 Interaction in Human Podocytes
Thrombin Induces Protease Activated Receptor (PAR)-3/-4 Interaction in Human Podocytes
Abstract
INTRODUCTION
Nephrotic Syndrome, one of the most common forms of glomerular disease, is characterized by massive proteinuria with structural ...
Title: GPC3 in the Exosomes from Hepatocellular Carcinoma HepG2 Cells
Title: GPC3 in the Exosomes from Hepatocellular Carcinoma HepG2 Cells
Abstract
Background
Exosomes play an important role in regulating the growth in normal and abnormal cells. Exosomes secreted from tumor cells are also involved in regulati...
Tumor Cells Talk to Normal Cells Through Exosomes to Rebuild the Tumor Microenvironment
Tumor Cells Talk to Normal Cells Through Exosomes to Rebuild the Tumor Microenvironment
Abstract
BackgroundExosomes play a key role in the growth of normal cells and various diseases such as cancer. Tumor exosomes regulate the connection between normal cells a...
Endothelial Protein C Receptor
Endothelial Protein C Receptor
IntroductionThe protein C anticoagulant pathway plays a critical role in the negative regulation of the blood clotting response. The pathway is triggered by thrombin, which allows ...
The p38 mitogen-activated protein kinase pathway plays a critical role in thrombin-induced endothelial chemokine production and leukocyte recruitment
The p38 mitogen-activated protein kinase pathway plays a critical role in thrombin-induced endothelial chemokine production and leukocyte recruitment
AbstractThrombin, the terminal serine protease in the coagulation cascade, is a proinflammatory molecule in vivo and induces endothelial activation in vitro. The cellular signaling...
Negative Regulation by p70 S6 Kinase of FGF-2–Stimulated VEGF Release Through Stress-Activated Protein Kinase/c-Jun N-Terminal Kinase in Osteoblasts
Negative Regulation by p70 S6 Kinase of FGF-2–Stimulated VEGF Release Through Stress-Activated Protein Kinase/c-Jun N-Terminal Kinase in Osteoblasts
Abstract
To clarify the mechanism of VEGF release in osteoblasts, we studied whether p70 S6 kinase is involved in basic FGF-2–stimulated VEGF release in osteoblast-l...
DNMT1/PKR double knockdowned HepG2 (HepG2-DP) cells have high hepatic function and differentiation ability
DNMT1/PKR double knockdowned HepG2 (HepG2-DP) cells have high hepatic function and differentiation ability
Abstract
HepG2 cells are widely used as a human hepatocytes model, but their functions, including drug metabolism, are inferior to primary hepatocytes. We previously report...

